Many drugs that are administered in an unmodified form by conventional systemic routes fail
to reach target organs in an effective concentration, or are not effective over a length of time …

Cardiovascular disease has become the leading cause of death. A vascular stent is an
effective means for the treatment of cardiovascular diseases. In recent years, biodegradable …

Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality
worldwide. Vascular inflammation is closely related to the pathogenesis of a diverse group …

Recent investigations have demonstrated that polydopamine (PDA)-modified surfaces were
beneficial to the proliferation of endothelial cells (ECs). In this work, PDA coated 316L …

The distressed personality (Type D) is an emerging risk factor in cardiovascular disease
(CVD) that incurs a risk on par with left ventricular dysfunction in patients with ischemic heart …

The main adverse reactions to coronary stents are in-stent restenosis (ISR) and stent
thrombosis. Along with procedural factors, individual susceptibility to these events plays an …

Mimicking the nitric oxide (NO)-release and glycocalyx functions of native vascular
endothelium on cardiovascular stent surfaces has been demonstrated to reduce in-stent …

Platelets play a pivotal role in chronic inflammation leading to progression of atherosclerosis
and acute coronary events. Recent discoveries on novel mechanisms and platelet …

Inflammation is central to the pathogenesis of acute coronary syndrome (ACS) and is
associated with adverse clinical outcomes after percutaneous coronary intervention (PCI) …

Vascular repair upon vessel injury is essential for the maintenance of arterial homeostasis
and function. Stem/progenitor cells were demonstrated to play a crucial role in regeneration …